Literature DB >> 2544401

Parathyroid hormone (PTH)-related protein is a potent stimulator of osteoclast-like multinucleated cell formation to the same extent as PTH in mouse marrow cultures.

T Akatsu1, N Takahashi, N Udagawa, K Sato, N Nagata, J M Moseley, T J Martin, T Suda.   

Abstract

Induction of osteoclast-like multinucleated cells (MNCs) by various fragments of PTH-related protein (PTHrP) was examined in mouse marrow cultures. Osteoclast-like MNCs were defined as tartrate-resistant acid phosphatase (TRACP)-positive MNCs with calcitonin receptors. In all experimental protocols examined, PTHrP-(1-34) induced TRACP-positive MNCs at almost the same rate as PTH-(1-34). PTHrP-(1-29) was less potent than PTHrP-(1-34). PTHrP-(1-25) and PTHrP-(1-14) had no effect. PTHrP-(1-34) was more potent than PTH-(1-34) in increasing the accumulation of cAMP, but the former appeared to lose its activity more rapidly than the latter. Isobutylmethylxanthine increased the effect of PTHrP-(1-34) and PTH-(1-34) in inducing TRACP-positive MNCs. Furthermore, the calcium ionophore A23187 significantly increased the formation of TRACP-positive MNCs. The effect of PTH-(1-34) and PTHrP-(1-34) in inducing TRACP-positive MNCs was potentiated by adding A23187 but suppressed by adding verapamil simultaneously. The inhibition by verapamil was overcome by adding A23187. [Nle8,18,Tyr34]PTH-(3-34)amide inhibited the effect of not only PTH-(1-34) but also PTHrP-(1-34) in inducing both the accumulation of cAMP and the TRACP-positive MNC formation. These results show that PTHrP is a potent stimulator of osteoclast-like MNC formation to almost the same extent as PTH. It increases the number of osteoclast-like MNCs by a mechanism involving cAMP and calcium ions, and is most likely mediated through the same receptor. The controversial results of the bone-resorbing activity of PTH and PTHrP reported so far may be explained by the differences in the relative potencies of the respective hormones in increasing the intracellular cAMP and calcium ions and by the shorter half-life of PTHrP in culture medium.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2544401     DOI: 10.1210/endo-125-1-20

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

Review 1.  Historically significant events in the discovery of RANK/RANKL/OPG.

Authors:  T John Martin
Journal:  World J Orthop       Date:  2013-10-18

Review 2.  Parathyroid hormone-like peptide.

Authors:  Daniel J Drucker
Journal:  Endocr Pathol       Date:  1991-03       Impact factor: 3.943

3.  Gallbladder carcinoma with osteoclast-like giant cells.

Authors:  Tomotaka Akatsu; Kaori Kameyama; Shigeyuki Kawachi; Minoru Tanabe; Koichi Aiura; Go Wakabayashi; Masakazu Ueda; Motohide Shimazu; Masaki Kitajima
Journal:  J Gastroenterol       Date:  2006-01       Impact factor: 7.527

4.  Functional and structural interactions between osteoblastic and preosteoclastic cells in vitro.

Authors:  S Z Orlandini; L Formigli; S Benvenuti; L Lasagni; A Franchi; L Masi; P A Bernabei; V Santini; M L Brandi
Journal:  Cell Tissue Res       Date:  1995-07       Impact factor: 5.249

5.  Interleukin-11: a new cytokine critical for osteoclast development.

Authors:  G Girasole; G Passeri; R L Jilka; S C Manolagas
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

6.  Giant cell tumor of bone: a neoplasm or a reactive condition?

Authors:  Anwar Ul Haque; Ambreen Moatasim
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

7.  Curcumin diminishes human osteoclastogenesis by inhibition of the signalosome-associated I kappaB kinase.

Authors:  Ivana von Metzler; Holger Krebbel; Ulrike Kuckelkorn; Ulrike Heider; Christian Jakob; Martin Kaiser; Claudia Fleissner; Evangelos Terpos; Orhan Sezer
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-03       Impact factor: 4.553

8.  Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.

Authors:  T Tamura; N Udagawa; N Takahashi; C Miyaura; S Tanaka; Y Yamada; Y Koishihara; Y Ohsugi; K Kumaki; T Taga
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

9.  Vitamin D3 differentially regulates parathyroid hormone/parathyroid hormone-related peptide receptor expression in bone and cartilage.

Authors:  N Amizuka; M Y Kwan; D Goltzman; H Ozawa; J H White
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

10.  Calcium regulating activity of 26,27-dimethyl analog of 24R,25-dihydroxyvitamin D3.

Authors:  T Miyahara; M Harada; S Kondo; H Komiyama; S Matsuda; A Miyanishi; M Matsumoto; W Xue-Ya; Y Ikemoto; A Sugure
Journal:  Calcif Tissue Int       Date:  1994-09       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.